Guardian Pharmacy Services (GRDN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
23 Mar, 2026Leadership and experience
Co-founders have deep industry experience, including prior successful exits and leadership roles in pharmacy and healthcare services.
Investor relations led by a seasoned equity markets professional with experience at major financial institutions.
Market positioning and opportunity
Focused on the $7 billion ALF and memory care pharmacy market, serving over 1 million residents.
Holds a 13% nationwide ALF market share, serving approximately 140,000 ALF residents and 205,000 total residents.
Market is highly fragmented with over 1,200 independent pharmacies, offering significant growth potential.
Business model and competitive advantages
Service-led, tech-enabled model with local service and centralized support, driving high adoption rates (~90%) in ALF.
Proprietary technology ecosystem integrates robotics, eMAR, and clinical intelligence for improved accuracy and adherence.
High barriers to entry due to regulatory complexity, scale requirements, and need for specialized talent.
Latest events from Guardian Pharmacy Services
- Annual meeting to vote on directors, executive pay, say-on-pay frequency, and auditor ratification.GRDN
Proxy filing26 Mar 2026 - Annual meeting to vote on directors, executive pay, auditor, and governance changes.GRDN
Proxy filing26 Mar 2026 - Momentum from vaccines, M&A, and innovation drives growth amid easing IRA headwinds.GRDN
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - Raised 2026 Adjusted EBITDA guidance after strong 2025 growth and robust cash generation.GRDN
Q4 202513 Mar 2026 - Expanding market share in assisted living pharmacy through organic growth and disciplined M&A.GRDN
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Assisted living market focus, tech-enabled growth, and IRA headwinds offset by direct payer strategy.GRDN
Stephens Annual Investment Conference3 Feb 2026 - Tech-enabled growth and disciplined expansion drive 13% ALF pharmacy market share.GRDN
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - Q3 2024 revenue up 20% year-over-year, but net loss driven by IPO-related expenses.GRDN
Q3 202414 Jan 2026 - Focused assisted living growth, tech innovation, and M&A drive expansion amid IRA headwinds.GRDN
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026